PHARMACIELO LTD.PHARMACIELO LTD.PHARMACIELO LTD.

PHARMACIELO LTD.

No trades
See on Supercharts
Next report date
Report period
Q4 2023
EPS estimate
0.03USD
Revenue estimate
‪13.41 M‬USD
Market capitalization
‪14.63 M‬USD
−0.0601USD
‪−10.71 M‬USD
‪3.92 M‬USD
‪149.14 M‬
Beta (1Y)
2.45

About PHARMACIELO LTD.

CEO
Marc Lustig
Headquarters
Toronto
Founded
2014
FIGI
BBG00N6NJ1S9
PharmaCielo Ltd. operates as a pharmaceutical company. It engages in the processing and supplying all natural, medicinal-grade cannabis oil extracts, and related products to large channel distributors. PharmaCielo's principal and wholly owned subsidiary is PharmaCielo Colombia Holdings S.A.S. The company was founded on July 14, 2014 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where PCLOF is featured.

Frequently Asked Questions

The current price of PCLOF is 0.1139 USD — it has increased by 2.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PHARMACIELO LTD. stocks are traded under the ticker PCLOF.
PHARMACIELO LTD. is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
PCLOF stock is 2.28% volatile and has beta coefficient of 2.45. Check out the list of the most volatile stocks — is PHARMACIELO LTD. there?
PHARMACIELO LTD. revenue for the last quarter amounts to ‪343.47 K‬ USD despite the estimated figure of ‪4.95 M‬ USD. In the next quarter revenue is expected to reach ‪6.17 M‬ USD.
Yes, you can track PHARMACIELO LTD. financials in yearly and quarterly reports right on TradingView.
PCLOF stock has fallen by 12.25% compared to the previous week, the month change is a 13.43% fall, over the last year PHARMACIELO LTD. has showed a 19.22% decrease.
PCLOF net income for the last quarter is ‪−2.03 M‬ USD, while the quarter before that showed ‪−2.70 M‬ USD of net income which accounts for 24.86% change. Track more PHARMACIELO LTD. financial stats to get the full picture.
Today PHARMACIELO LTD. has the market capitalization of ‪18.09 M‬, it has decreased by 12.33% over the last week.
No, PCLOF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PCLOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMACIELO LTD. stock right from TradingView charts — choose your broker and connect to your account.
PCLOF reached its all-time high on Mar 27, 2019 with the price of 9.9750 USD, and its all-time low was 0.0792 USD and was reached on Aug 21, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMACIELO LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMACIELO LTD. stock shows the sell signal. See more of PHARMACIELO LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMACIELO LTD. EBITDA is ‪−6.04 M‬ USD, and current EBITDA margin is −161.84%. See more stats in PHARMACIELO LTD. financial statements.